UBS Group’s Cogentix Medical, Inc. CGNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-12,512
| Closed | -$48K | – | 8586 |
|
|
2018
Q1 | $48K | Buy |
+12,512
| New | +$39.2K | ﹤0.01% | 5753 |
|
|
2017
Q4 | – | Sell |
-2,427
| Closed | -$6K | – | 8346 |
|
|
2017
Q3 | $6K | Sell |
2,427
-4,156
| -63% | -$9.11K | ﹤0.01% | 7187 |
|
|
2017
Q2 | $11K | Sell |
6,583
-2,076
| -24% | -$3.56K | ﹤0.01% | 6748 |
|
|
2017
Q1 | $16K | Buy |
8,659
+7,277
| +527% | +$14.4K | ﹤0.01% | 6334 |
|
|
2016
Q4 | $3K | Sell |
1,382
-2,010
| -59% | -$4.11K | ﹤0.01% | 7465 |
|
|
2016
Q3 | $6K | Buy |
3,392
+2,004
| +144% | +$2.59K | ﹤0.01% | 7096 |
|
|
2016
Q2 | $1K | Buy |
+1,388
| New | +$1.37K | ﹤0.01% | 7619 |
|
|
2016
Q1 | – | Sell |
-821
| Closed | -$1K | – | 8549 |
|
|
2015
Q4 | $1K | Sell |
821
-5,134
| -86% | -$7.02K | ﹤0.01% | 8222 |
|
|
2015
Q3 | $7K | Buy |
5,955
+1,009
| +20% | +$1.55K | ﹤0.01% | 7541 |
|
|
2015
Q2 | $8K | Buy |
+4,946
| New | +$8.1K | ﹤0.01% | 7641 |
|
UBS Group's CGNT Position: Q2 2018 in Review
UBS Group sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 12,512 shares — an estimated $48K sold.
UBS Group first reported a position in CGNT in Q2 2015 and held it in 10 quarters. The position peaked at $48K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.
- UBS Group reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
- UBS Group sold 12,512 Cogentix Medical, Inc. shares in Q2 2018, an estimated $48K.
- UBS Group first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 10 quarters.
- UBS Group's Cogentix Medical, Inc. position peaked at $48K in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.
Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.